Pro Dex Inc financial data

Symbol
PDEX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2361 Mcgaw Avenue, Irvine, CA
Fiscal year end
June 30
Latest financial report
10-Q - Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 352 % +25.6%
Quick Ratio 161 % +23%
Debt-to-equity 83.1 % -49.6%
Return On Equity 8.72 % -83.5%
Return On Assets 4.02 % -72.6%
Operating Margin 13 % +17.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.42M shares -3.56%
Common Stock, Shares, Outstanding 3.45M shares -2.65%
Entity Public Float 32.5M USD -35.1%
Common Stock, Value, Issued 5.58M USD -15.3%
Weighted Average Number of Shares Outstanding, Basic 3.55M shares -0.76%
Weighted Average Number of Shares Outstanding, Diluted 3.61M shares -1.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 49.5M USD +2.9%
Cost of Revenue 35.6M USD +1.15%
Research and Development Expense 3.05M USD +7.48%
General and Administrative Expense 4.25M USD -5.2%
Operating Income (Loss) 6.43M USD +20.6%
Nonoperating Income (Expense) 485K USD -52.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.72M USD -71.4%
Income Tax Expense (Benefit) 678K USD -67.6%
Net Income (Loss) Attributable to Parent 2.04M USD -72.4%
Earnings Per Share, Basic 0.58 USD/shares -72%
Earnings Per Share, Diluted 0.58 USD/shares -71.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.22M USD +54.2%
Marketable Securities, Current 1M USD
Accounts Receivable, after Allowance for Credit Loss, Current 12.5M USD +18.5%
Inventory, Net 14.2M USD -5.96%
Assets, Current 36M USD +15.5%
Deferred Income Tax Assets, Net 764K USD +65%
Property, Plant and Equipment, Net 5.19M USD +0.56%
Operating Lease, Right-of-Use Asset 1.58M USD -20%
Intangible Assets, Net (Excluding Goodwill) 61K USD -29.9%
Other Assets, Noncurrent 42K USD 0%
Assets 50.5M USD -2.21%
Accounts Payable, Current 3.44M USD +12%
Accrued Liabilities, Current 2.7M USD +11.4%
Liabilities, Current 10.4M USD +2.71%
Long-term Debt and Lease Obligation 10.6M USD -9.64%
Accrued Income Taxes, Noncurrent 1.16M USD -3.56%
Deferred Income Tax Liabilities, Net 8K USD -98.8%
Operating Lease, Liability, Noncurrent 1.3M USD -25.6%
Liabilities 19.6M USD -9.98%
Retained Earnings (Accumulated Deficit) 25.4M USD +8.76%
Stockholders' Equity Attributable to Parent 30.9M USD +3.45%
Liabilities and Equity 50.5M USD -2.21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 392K USD -86.4%
Net Cash Provided by (Used in) Financing Activities -1.3M USD -52.2%
Net Cash Provided by (Used in) Investing Activities -126K USD -40%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 3.45M shares -2.65%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.22M USD +54.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 140K USD +57.3%
Deferred Tax Assets, Valuation Allowance 91K USD -7.14%
Deferred Tax Assets, Gross 3.1M USD +24.8%
Operating Lease, Liability 1.75M USD -18.9%
Depreciation 23K USD 0%
Payments to Acquire Property, Plant, and Equipment 126K USD -29.2%
Lessee, Operating Lease, Liability, to be Paid 1.93M USD -21.1%
Property, Plant and Equipment, Gross 13.4M USD +1.62%
Operating Lease, Liability, Current 445K USD +9.61%
Lessee, Operating Lease, Liability, to be Paid, Year Two 551K USD +6.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 535K USD +321%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 80K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 181K USD -37.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 567K USD +5.98%
Deferred Tax Assets, Operating Loss Carryforwards 22K USD 0%
Unrecognized Tax Benefits 69K USD +16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 143K USD -74%
Operating Lease, Payments 516K USD +0.78%
Depreciation, Depletion and Amortization 282K USD +46.1%
Deferred Tax Assets, Net of Valuation Allowance 3.01M USD +26.1%
Interest Expense 554K USD +9.92%